Skip to Content

New Drug Approvals Archive - December 2010

See also: New Indications and Dosage Forms for December 2010

December 2010

Safyral (drospirenone, ethinyl estradiol and levomefolate calcium) Tablets

Date of Approval: December 16, 2010
Company: Bayer HealthCare Pharmaceuticals, Inc.
Treatment for: Contraception

Safyral (drospirenone, ethinyl estradiol and levomefolate calcium) is an estrogen/progestin combined oral contraceptive containing a folate, indicated for use by women to prevent pregnancy, and to raise folate levels in women who choose to use an oral contraceptive for contraception.

Amturnide (aliskiren, amlodipine and hydrochlorothiazide) Tablets

Date of Approval: December 21, 2010
Company: Novartis Pharmaceuticals Corporation
Treatment for: Hypertension

Amturnide (aliskiren, amlodipine and hydrochlorothiazide) is a direct renin inhibitor, calcium channel blocker and diuretic combination for the treatment of high blood pressure.

Fortesta (testosterone) Gel

Date of Approval: December 29, 2010
Company: Endo Pharmaceuticals
Treatment for: Hypogonadism -- Male

Fortesta (testosterone) Gel is a topical androgen indicated for replacement therapy in male hypogonadism.

New Drug Approvals Archive

More News Resources

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.